[1]
D. TANDON, “RESISTIN GENE POLYMORPHISMS: POTENTIAL BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA”, Int J Pharm Pharm Sci, vol. 16, no. 2, pp. 30–35, Feb. 2024.